News Release

Media Advisory

The Scripps Research Institute and IAVI Host Leading Scientists Searching for New Ways to Produce an HIV/AIDS Vaccine

Media Briefing will present recent significant progress and symposium highlights; interview opportunities; lab tour


International Symposium "Toward a Vaccine that Elicits Broadly Neutralizing Antibodies against HIV." More than 70 leading HIV/AIDS vaccine researchers will gather to discuss recent scientific advances in the quest to develop an AIDS vaccine. 

Media Briefing by two experts from the IAVI/Scripps Research team that recently discovered two new broadly neutralizing antibodies to HIV that reveal a previously unknown site on the virus that could prove a good target for vaccine design. They will discuss the implications of their work, which was published in the September 3 online edition of the journal Science, and the research road ahead.

One-on-one interviews with Wayne Koff, senior vice president of research and development at IAVI, and Dennis R. Burton, scientific director of the IAVI Neutralizing Antibody Consortium and Scripps Research professor in the Department of Immunology.

Laboratory tour for B-roll

Interview opportunities with presenting and attending scientists during symposium breaks


Beckman Center for Chemical Sciences
at The Scripps Research Institute
10550 North Torrey Pines Road
La Jolla, California 92037 

Symposium: Lower Level, Beckman Center

Media Briefing: 4th Floor Atrium Meeting Room, Beckman Center

WHEN: Thursday, September 24

Symposium: 8:30 AM to 5:00 PM PDT

Media Briefing: 10:15 to 10:45 AM PDT

Briefing Call-in: Dial toll-free 1-866-618-6746; when prompted, enter access code 3579711 followed by #. 


Please contact Office of Communications

or Rachel Steinhardt


Daphne Lovelette at Scripps Research

For more information contact:
Office of Communications
10550 North Torrey Pines Road
La Jolla, California 92037

For more information, contact See More News